



Diversified Consumer Services | Small Cap
Docmode Health Technologies operates within the competitive Consumer Services sector, specifically Hospitality & Leisure. The company demonstrates a mixed financial performance. Strengths include solid solvency, driven by a healthy equity position and manageable debt levels, and robust efficiency in utilizing fixed assets and inventory. The company has also experienced good revenue and asset growth. Profitability metrics show positive returns on capital employed and equity, alongside a manageable operating margin. However, certain areas need attention, including liquidity, which is constrained by low current and cash ratios. Growth is hampered by negative trends in operating profit, EPS, and net income. Coverage ratios are weak, indicating challenges in covering interest and dividend obligations. Financial ratios are also mixed, with low book value per share and inconsistent earnings performance. Overall, Docmode Health Technologies shows potential but needs to address key financial weaknesses to ensure sustained success.
Docmode Health Technologies operates within the competitive Consumer Services sector, specifically Hospitality & Leisure. The company demonstrates a mixed financial performance. Strengths include solid solvency, driven by a healthy equity position and manageable debt levels, and robust efficiency in utilizing fixed assets and inventory. The company has also experienced good revenue and asset growth. Profitability metrics show positive returns on capital employed and equity, alongside a manageable operating margin. However, certain areas need attention, including liquidity, which is constrained by low current and cash ratios. Growth is hampered by negative trends in operating profit, EPS, and net income. Coverage ratios are weak, indicating challenges in covering interest and dividend obligations. Financial ratios are also mixed, with low book value per share and inconsistent earnings performance. Overall, Docmode Health Technologies shows potential but needs to address key financial weaknesses to ensure sustained success.
Overall Valuation Score
Markets Depth NSE
Buy Orders
Bid
Quantity
Orders
No buy depth
Total
0
0
Sell Orders
Ask
Quantity
Orders
No sell depth
Total
0
0
Markets Today NSE
High
0.00
Low
0.00
Open
0.00
Close
0.00
Prev Close
0.00
Avg Price
0.00
Volume
0
Last Traded Quantity
0
Last Traded Time
N/A
Price Movement Indicator
Today's Low: 0.00
Today's High: 0.00
P/E RATIO (TTM)
N/A
Industry Median
23.43
Small Cap Median
23.43
P/E RATIO
-6.90
P/B RATIO
1.68
Industry Median
1.98
Small Cap Median
1.98
P/S RATIO
0.33
Industry Median
2.99
Small Cap Median
2.99
Others
PEG RATIO
0.00
EV/EBITDA RATIO
52.42
The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹44.6 as on Feb 20, 2026.
Growth ratios assess the rate at which a company expands. The company has experienced strong revenue and asset growth, reflecting business expansion. However, there are significant negative trends in operating profit, EPS, and net income growth, indicating potential challenges in profitability and earnings. Addressing these negative growth trends is crucial for sustained long-term success.
| Growth Ratios | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Revenue Growth Rate | 2.31 | 74.93 | 164.73 | 21.44 | 4.46 |
| Operating Profit Growth Rate | 123.08 | 117.24 | 97.88 | -49.73 | -136.17 |
| Earnings Per Share (EPS) Growth | -92.94 | -1176.67 | |||
| Asset Growth Rate | 77.78 | 68.75 | 77.25 | 30.38 | |
| Net Income Growth Rate | 61.76 | 67.27 | 111.96 | -90.26 | -1168.42 |
Revenue Growth Rate
Operating Profit Growth Rate
Earnings Per Share (EPS) Growth
Asset Growth Rate
Net Income Growth Rate
Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.
| NO | Company Name | Health Score | P/E Ratio | Valuation | OPM | EPS | Latest Profit & Loss |
|---|---|---|---|---|---|---|---|
| 1 | Usha Martin Education & Solutions Ltd | 6.65 | 40.13 | Neutral | 0.44 | 0.14 | 0.39 |
| 2 | Docmode Health Technologies Ltd | 6.05 | -6.90 | Neutral | -0.68 | -6.46 | -2.03 |
| 3 | DSJ Keep Learning Ltd | 5.05 | -32.00 | Neutral | -0.76 | -0.06 | -0.97 |
| 4 | MT Educare Ltd | 3.93 | -2.24 | Neutral | -4.74 | -0.85 | -6.16 |
| 5 | Educomp Solutions Ltd | N/A | N/A | N/A | N/A | N/A | N/A |
0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 1 Technical Indicators From The 1 Hour Timeframe
Docmode Health Technologies Ltd operates an online learning and knowledge-sharing platform for healthcare professionals globally. It offers accredited medical education (CMEs), clinical resources, and networking opportunities, aiming to bridge knowledge gaps and enhance skills for doctors, nurses, and allied healthcare workers, thereby improving patient outcomes.
P/E Ratio (TTM): Price to Earnings ratio shows how much an investor pays for every rupee of the company's earnings. Docmode Health Technologies Ltd's P/E ratio (TTM) is -6.90, compared to the industry median of 23.43 and large cap median of 23.43.
P/B Ratio: Price to Book ratio compares a company's market price to its book value per share. Docmode Health Technologies Ltd's P/B ratio is 1.68, compared to the industry median of 1.98 and large cap median of 1.98.
P/S Ratio: Price to Sales ratio compares a company's market value to its total revenue. Docmode Health Technologies Ltd's P/S ratio is 0.33, compared to the industry median of 2.99 and large cap median of 2.99.
PEG Ratio: PEG ratio adjusts the P/E ratio for expected earnings growth. Docmode Health Technologies Ltd's PEG ratio is 2.20.
EV/EBITDA Ratio: This ratio compares a company's enterprise value to its earnings before interest, tax, depreciation, and amortization. Docmode Health Technologies Ltd's EV/EBITDA ratio is 52.42.
Return on Equity (ROE): ROE measures how much profit a company generates from shareholders' invested capital. Docmode Health Technologies Ltd's ROE is -24.31%.
Return on Assets (ROA): ROA measures how efficiently a company converts its assets into net profit. Docmode Health Technologies Ltd's ROA is -1.73%.
Return on Capital Employed (ROCE): ROCE measures how efficiently a company generates profit from all the capital it employs. Docmode Health Technologies Ltd's ROCE is -0.29%.
Operating Margin: Operating margin shows what percentage of revenue remains after covering operating expenses. Docmode Health Technologies Ltd's operating margin is -1.63%.
Net Margin: Net margin shows what percentage of revenue converts into final net profit. Docmode Health Technologies Ltd's net margin is -4.87%.
Current Ratio: The current ratio measures a company's ability to pay short-term liabilities using short-term assets. Docmode Health Technologies Ltd's current ratio is 0.84.
Debt to Equity Ratio: This ratio shows the proportion of debt a company uses relative to shareholders' equity. Docmode Health Technologies Ltd's debt-to-equity ratio is 0.14.
Interest Coverage Ratio: This ratio shows how easily a company can pay interest on its outstanding debt from its operating earnings. Docmode Health Technologies Ltd's interest coverage ratio is -0.03.
Dividend Per Share (DPS): DPS shows the total dividend paid per share in the latest financial year. Docmode Health Technologies Ltd's DPS is ₹0.
Earnings Per Share (EPS): EPS shows how much profit is allocated to each outstanding share. Docmode Health Technologies Ltd's EPS is -1176.67.
(Source line: "Ratios as of 20 Feb 2026, based on last traded price of ₹44.60. Data sourced from BSE/NSE Exchange Filings & Public Terminal Data.")
Founded: 2020
Headquarters: Mumbai, Maharashtra
Core Offerings: Online Medical Education (CMEs), Clinical Resource Library, Healthcare Professional Networking, Medical News & Updates, Skill Enhancement Programs
Stock Listing: NSE (DHTL), BSE ({bse})
Promoter: Dr. Hans Albert Lewis, Mr. Paulson Paul, Mr. Jaison Paulson
Incorporated in 2020, Docmode Health Technologies Ltd quickly established itself as a digital platform dedicated to medical learning and professional development. The company successfully launched its Initial Public Offering (IPO) on the NSE SME platform in January 2024, marking a significant milestone. It continues to expand its digital reach and diversify its offerings within the online medical education and healthcare professional engagement space.
| Segment Name | Revenue % | EBITDA |
|---|---|---|
| Digital Medical Learning & Professional Development | 100% | N/A (Integrated Segment) |
Digital Medical Learning & Professional Development: Offers a comprehensive online platform for doctors, nurses, and allied healthcare professionals, featuring accredited Continuing Medical Education (CME) courses, clinical decision-making tools, and a vast library of medical resources.
Professional Networking & Insights: Facilitates interaction among healthcare peers and provides access to the latest medical news, research, and industry insights, fostering continuous learning and collaboration for improved patient care.
Dr. Hans Albert Lewis, Chairman & Managing Director. A visionary leader with extensive experience in the healthcare and digital sectors, he has been instrumental in shaping Docmode's strategic direction and growth since its inception.
['DocMode International FZ LLC (based in UAE, focusing on international market expansion)']
Launched Initial Public Offering (IPO) on NSE SME platform in January 2024.
The Docmode Health Technologies Ltd share price today is ₹44.60 on NSE (DHTL), as of 19 Aug 2026.
As of 20 Feb 2026, Docmode Health Technologies Ltd share price is ₹44.60, with previous close ₹N/A. Today's range is ₹N/A to ₹N/A. The 52-week range is ₹N/A to ₹N/A.
As of today, Docmode Health Technologies Ltd's market cap is ₹13.83 crore (Small Cap).
Docmode Health Technologies Ltd's current P/E ratio is -6.90, compared to the DIVERSIFIED CONSUMER SERVICES sector average of 67.
Docmode Health Technologies Ltd's current P/B ratio is 1.68.
Docmode Health Technologies Ltd's current dividend yield is N/A. Last dividend of ₹0.00 per share was declared on N/A.
Docmode Health Technologies Ltd's EPS (TTM) is ₹-1176.67.
Docmode Health Technologies Ltd operates an online learning and knowledge-sharing platform for healthcare professionals globally. It offers accredited medical education (CMEs), clinical resources, and networking opportunities, aiming to bridge knowledge gaps and enhance skills for doctors, nurses, and allied healthcare workers, thereby improving patient outcomes.
Docmode Health Technologies Ltd is promoted by Dr. Hans Albert Lewis, Mr. Paulson Paul, Mr. Jaison Paulson, holding 9.18% as of 20 Feb 2026.
Docmode Health Technologies Ltd is listed on NSE (DHTL) and BSE ({bse}). Its next quarterly results are expected on August 2024.